• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年冠状病毒病反复感染后Good综合征的诊断

Diagnosis of Good Syndrome following Recurrent Coronavirus Disease-2019 Infections.

作者信息

Beiser Moshe, Sabari Joshua K

机构信息

Langone Department of Internal Medicine, New York University, New York, NY, USA.

Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.

出版信息

Case Rep Oncol. 2025 Jan 14;18(1):107-112. doi: 10.1159/000542928. eCollection 2025 Jan-Dec.

DOI:10.1159/000542928
PMID:39980518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731910/
Abstract

BACKGROUND

Good syndrome is defined as the co-occurrence of a thymoma and hypogammaglobulinemia.

CASE

In this case report, we present a patient who was diagnosed with Good syndrome following recurrent infections with SARS-CoV-2. Of particular note was the patient's repeated presentation despite receiving outpatient treatment with nirmatrelvir-ritonavir. We describe the patient's presentation, diagnosis, and treatment - including robotic thymectomy and passive immunization with IVIG - and report the benefit to quality of life that the patient experienced.

CONCLUSION

This case highlights the importance of quantitative testing of immunoglobulins in patients with known thymomas who present with recurrent infections of SARS-CoV-2.

摘要

背景

古德综合征的定义为胸腺瘤与低丙种球蛋白血症同时出现。

病例

在本病例报告中,我们介绍了一名患者,该患者在感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后反复感染,被诊断为古德综合征。特别值得注意的是,尽管该患者接受了奈玛特韦-利托那韦的门诊治疗,但仍反复出现症状。我们描述了该患者的症状、诊断和治疗情况,包括机器人辅助胸腺切除术和静脉注射免疫球蛋白(IVIG)被动免疫,并报告了患者生活质量得到改善的情况。

结论

本病例强调了对已知患有胸腺瘤且出现SARS-CoV-2反复感染的患者进行免疫球蛋白定量检测的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb50/11731910/4adc31f9407e/cro-2025-0018-0001-542928_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb50/11731910/4adc31f9407e/cro-2025-0018-0001-542928_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb50/11731910/4adc31f9407e/cro-2025-0018-0001-542928_F01.jpg

相似文献

1
Diagnosis of Good Syndrome following Recurrent Coronavirus Disease-2019 Infections.2019年冠状病毒病反复感染后Good综合征的诊断
Case Rep Oncol. 2025 Jan 14;18(1):107-112. doi: 10.1159/000542928. eCollection 2025 Jan-Dec.
2
Case report and literature review on Good's syndrome, a form of acquired immunodeficiency associated with thymomas.关于古德综合征(一种与胸腺瘤相关的获得性免疫缺陷形式)的病例报告及文献综述。
Hawaii J Med Public Health. 2013 Feb;72(2):56-62.
3
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
4
Recurrent neutropenia and chronic diarrhea following thymectomy: the good, the bad, and the ugly.胸腺切除术后复发性中性粒细胞减少和慢性腹泻:有利、有弊、有风险。
J Community Hosp Intern Med Perspect. 2021 Mar 23;11(2):263-265. doi: 10.1080/20009666.2021.1877400.
5
Thymoma complicated with myasthenia gravis and Good syndrome - a therapeutic conundrum: a case report.胸腺瘤合并重症肌无力及古德综合征——治疗难题:一例病例报告
J Med Case Rep. 2019 Nov 29;13(1):348. doi: 10.1186/s13256-019-2289-z.
6
Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China.五例中国 Good 综合征患者(胸腺瘤伴低丙种球蛋白血症)的临床特征和实验室结果的多变性:中国一所大学医院的 8 年回顾性分析。
BMC Immunol. 2021 Aug 3;22(1):50. doi: 10.1186/s12865-021-00441-9.
7
Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.尼马曲韦/利托那韦治疗 SARS-CoV-2 阳性肾移植受者 - 四例病例系列。
BMC Nephrol. 2023 Apr 15;24(1):99. doi: 10.1186/s12882-023-03154-w.
8
Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good's syndrome.静脉注射免疫球蛋白替代疗法预防Good综合征患者肺部感染
J Microbiol Immunol Infect. 2015 Apr;48(2):229-32. doi: 10.1016/j.jmii.2012.09.003. Epub 2012 Nov 29.
9
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.在接受滤泡性淋巴瘤 CD20 耗竭治疗的免疫功能低下宿主中,使用联合抗病毒治疗(尼马曲韦/利托那韦和瑞德西韦)和静脉注射免疫球蛋白输注成功治疗持续性 COVID-19。
J Infect Chemother. 2024 Aug;30(8):793-795. doi: 10.1016/j.jiac.2024.01.008. Epub 2024 Jan 17.
10
Recurrent Opportunistic Infections in a Thymectomised Patient with Myasthenia Gravis and Good's Syndrome.一名行胸腺切除术的重症肌无力合并古德综合征患者的复发性机会性感染
Cureus. 2018 Aug 10;10(8):e3130. doi: 10.7759/cureus.3130.

本文引用的文献

1
Relapse of COVID-19 and Viral Evolution in a Patient With Good Syndrome: A Case Report.一例Good综合征患者的新型冠状病毒肺炎复发及病毒进化:病例报告
Cureus. 2024 Jan 19;16(1):e52592. doi: 10.7759/cureus.52592. eCollection 2024 Jan.
2
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
3
Thymoma: An Overview.胸腺瘤:概述
Diagnostics (Basel). 2023 Sep 18;13(18):2982. doi: 10.3390/diagnostics13182982.
4
Insights from a Case of Good's Syndrome (Immunodeficiency with Thymoma).一例古德综合征(胸腺瘤伴免疫缺陷)的见解。
Biomedicines. 2023 Jun 1;11(6):1605. doi: 10.3390/biomedicines11061605.
5
Good's syndrome and COVID-19: case report and literature review.古德综合征与新型冠状病毒肺炎:病例报告及文献综述
Mediastinum. 2022 Sep 9;7:5. doi: 10.21037/med-22-12. eCollection 2023.
6
Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review.复发 COVID-19 感染作为 Good 综合征的一种表现:病例报告及文献复习。
Int J Infect Dis. 2023 Apr;129:236-239. doi: 10.1016/j.ijid.2022.12.040. Epub 2023 Jan 3.
7
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.加利福尼亚州 2021 年 12 月至 2022 年 5 月辉瑞公司新冠口服药 Paxlovid 治疗后因 COVID-19 住院和急诊就诊情况。
MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):830-833. doi: 10.15585/mmwr.mm7125e2.
8
Clinical and radiological improvement of protracted COVID-19 and Good syndrome secondary to advanced thymoma.持续性新冠病毒感染及继发于晚期胸腺瘤的古德综合征的临床和影像学改善
Pulmonology. 2022 Nov-Dec;28(6):472-475. doi: 10.1016/j.pulmoe.2022.04.011. Epub 2022 May 10.
9
Good's Syndrome: Time to Move on From Reviewing the Past.Good's 综合征:是时候从回顾过去中走出来了。
Front Immunol. 2022 Jan 12;12:815710. doi: 10.3389/fimmu.2021.815710. eCollection 2021.
10
Are there any association between COVID-19 severity and immunosuppressive therapy?2019冠状病毒病的严重程度与免疫抑制治疗之间是否存在关联?
Immunol Lett. 2020 Aug;224:12-13. doi: 10.1016/j.imlet.2020.05.002. Epub 2020 May 28.